Urotensin-II protects against cardiovascular events in patients with kidney disease

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Nephrology | 2006年 / 2卷 / 7期
关键词：
D O I：
10.1038/ncpneph0196
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：350 / 350
相关论文
共 50 条
  • [21] Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure
    Dschietzig, T
    Bartsch, C
    Pregla, R
    Zurbrügg, HR
    Armbruster, FP
    Richter, C
    Laule, M
    Romeyke, E
    Neubert, C
    Voelter, W
    Baumann, G
    Stangl, K
    REGULATORY PEPTIDES, 2002, 110 (01) : 33 - 38
  • [22] Relaxin and urotensin-II concentrations in heart failure patients.
    Hammerer-Lercher, AM
    Ludwig, W
    Neubauer, E
    Müller, S
    Puschendorf, B
    Pachinger, O
    Armbruster, FP
    Neubert, C
    Mair, J
    CLINICAL CHEMISTRY, 2002, 48 (06) : A96 - A96
  • [23] Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease
    Douglas, SA
    Ohlstein, EH
    TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) : 229 - 237
  • [24] Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease
    San Bao Chai
    Xue Min Li
    Yong Zheng Pang
    Yong Fen Qi
    Chao Shu Tang
    Heart and Vessels, 2010, 25 : 138 - 143
  • [25] Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease
    Chai, San Bao
    Li, Xue Min
    Pang, Yong Zheng
    Qi, Yong Fen
    Tang, Chao Shu
    HEART AND VESSELS, 2010, 25 (02) : 138 - 143
  • [26] Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II
    Su, JL
    Ao, ZH
    Aiyar, NV
    Ellis, B
    Martin, JD
    Douglas, SA
    Kull, FC
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (06): : 377 - 382
  • [27] Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?
    Douglas, SA
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) : 159 - 167
  • [28] Urotensin-II Receptor Antagonist SB-710411 Protects Rat Heart against IschemiaReperfusion Injury via RhoA/ROCK Pathway
    Luo, Sheng-Yong
    Chen, Shuo
    Qin, Yi-De
    Chen, Zhi-Wu
    PLOS ONE, 2016, 11 (01):
  • [29] Human urotensin-II, the most potent mammalian vasoconstrictor identified, represents a novel therapeutic target in the treatment of cardiovascular disease
    Douglas, S
    Aiyar, NV
    Ohlstein, EH
    Willette, RN
    EUROPEAN HEART JOURNAL, 2000, 21 : 495 - 495
  • [30] Urotensin II system in chronic kidney disease
    Michael, Olugbenga S.
    Kanthakumar, Praghalathan
    Soni, Hitesh
    Lenin, Raji Rajesh
    Jha, Kumar Abhiram
    Gangaraju, Rajashekhar
    Adebiyi, Adebowale
    CURRENT RESEARCH IN PHYSIOLOGY, 2024, 7
12345